PCN27 COST-EFFECTIVENESS OF HUMAN INTERFERON-ALPHAAS ADJUVANT TREATMENT FOR PATIENTS WITH RESECTED CUTANEOUS MALIGNANT MELANOMA IN STAGE MB III
Nov 1, 2007, 00:00
10.1016/S1098-3015(10)65185-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)65185-6/fulltext
Title :
PCN27 COST-EFFECTIVENESS OF HUMAN INTERFERON-ALPHAAS ADJUVANT TREATMENT FOR PATIENTS WITH RESECTED CUTANEOUS MALIGNANT MELANOMA IN STAGE MB III
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65185-6&doi=10.1016/S1098-3015(10)65185-6
First page :
Section Title :
Open access? :
No
Section Order :
344